AVAV: The Drone Leader Wall Street Abandoned
Key Takeaways
- AVAV trades at $183, down 56% from highs, after a $151 million non-cash goodwill impairment and Raymond James triple-downgrade.
- Revenue surged 143% YoY to $408 million in Q3 FY2026, but gross margins compressed to 17% during acquisition integration.
- At 2.1x book value with a 5.51 current ratio, the balance sheet provides a margin of safety the stock price doesn't reflect.
- FY2028 estimates project $2.64 billion revenue and $5.73 EPS — a return to profitability driven by drone warfare tailwinds.
- The LOCUST X3 directed energy weapon opens a new counter-drone market at a time when every NATO military is accelerating procurement.
AeroVironment has lost 56% of its value since hitting $418 last year. At $183, the stock trades below where it sat before drone warfare became the defining military trend — the same wave lifting defense stocks broadly — of the decade. Raymond James triple-downgraded from strong buy to underperform. Pomerantz Law Firm announced an investor investigation. The consensus narrative is that AVAV overpaid for acquisitions and now faces margin compression.
The consensus is wrong on the timeline, if not the diagnosis.
AeroVironment's Q3 fiscal 2026 revenue hit $408 million — up 143% year-over-year — after integrating what appears to be a transformational acquisition that doubled its revenue base. Yes, gross margins compressed from 38% to 17%. Yes, there was a $151 million goodwill impairment. But those are integration costs, not structural failures. The company that dominates Switchblade loitering munitions, just unveiled the LOCUST X3 directed energy weapon, and sits at the center of every major military drone program is not worth less than it was before Ukraine proved the thesis.
Valuation: Distorted by One-Time Charges
AVAV's headline metrics look terrifying. Trailing P/E is negative (the company lost $217 million over the past four quarters). EV/EBITDA sits at 418x. Price-to-sales is 33x on a trailing basis.
But these numbers are distorted by acquisition accounting. Strip out the $151 million goodwill impairment charge from Q3, and the net loss drops to roughly $5 million — still not great, but a far cry from the $157 million loss that spooked the market. The impairment was a non-cash writedown of the Space reporting unit, not an operational failure in the core drone business.
<a href="/posts/deep-dive-price-to-book-ratio-how-to-use-pb-to-find-undervalued-stocks">Book value</a> is $87.61 per share, putting P/B at just 2.1x at the current $183 price. Intangibles make up 62% of assets (acquisition-driven), but tangible book of $18.14 per share shows the floor isn't zero. With $12.04 in cash per share and a current ratio of 5.51, this company has zero near-term liquidity risk.
On FY2028 estimates — revenue around $2.64 billion annually and EPS of roughly $5.73 — the forward P/E drops to 32x. For a defense company growing revenue at 40%+ annually with drone warfare tailwinds, that multiple isn't aggressive.
Earnings: Acquisition Noise Masks Real Progress
The quarterly earnings trajectory tells two stories. The bad story: three consecutive quarters of operating losses totaling $112 million. The better story: revenue scaled from $275 million (Q4 FY2025) to $473 million (Q2 FY2026), a 72% increase in just two quarters.
Gross margins compressed from 38% to 17-21% as the acquired business integrated. Q3's 17.1% margin was the trough — affected by contract timing issues and higher R&D investment. Management cut FY2026 adjusted EPS guidance to $2.75-$3.10 from $3.40-$3.55, acknowledging the integration is taking longer than planned.
The Q3 revenue miss of approximately $80 million below consensus was the trigger for the latest selloff. But revenue volatility is standard in defense — large contracts create lumpy quarterly results. The annual run rate matters more than any single quarter.
The SCAR Risk: Overblown or Legitimate?
The Pentagon's decision to reopen the Satellite Communications Augmentation Resource (SCAR) program for competitive bidding triggered Raymond James' triple-downgrade. The $1.4 billion Space Force contract for mobile ground stations was seen as a locked-in revenue stream — reopening it introduces competition risk.
This is a legitimate concern but a contained one. SCAR sits in the Space reporting unit — the same unit that just took the $151 million goodwill impairment. The market has already priced significant value destruction in this segment. Even a total loss of SCAR wouldn't materially change the investment thesis, which centers on tactical drone systems, not satellite ground stations. For another defense tech name navigating a selloff, see Axon Enterprise's profitability challenge.
AeroVironment's core drone business — Switchblade, Puma, and the Jump 20 family — remains dominant in its niches. No competitor matches Switchblade's deployed base or operator familiarity. The LOCUST X3 directed energy weapon announced March 24 opens an entirely new market in counter-drone defense, addressing the exact threat that Ukraine's battlefield has made urgent.
Defense Tailwinds Are Structural, Not Cyclical
Global defense spending on autonomous systems is accelerating, driven by the same geopolitical risk dynamics reshaping <a href="/posts/deep-dive-how-stock-buybacks-affect-share-price-and-earnings-why-big-tech-spends-billions-repurchasing-its-own-shares">capital allocation</a> across markets. Ukraine proved that cheap, attritable drones change the cost calculus of modern warfare — a $6,000 Switchblade can neutralize a $2 million armored vehicle. Every NATO military is now accelerating drone procurement, even as established primes like <a href="/posts/lmt-q2-margin-collapse-beneath-the-boom">Lockheed Martin face their own margin pressures</a>. While legacy primes like Boeing struggle with execution, nimble drone makers benefit.
AeroVironment has the manufacturing scale, the operational track record, and the product portfolio to capture outsized share. The Switchblade 600 (anti-armor) and Switchblade 300 (anti-personnel) are already fielded by US and allied forces. The company's loitering munitions category is growing faster than the broader defense budget.
The acquisition that tanked margins appears designed to add manufacturing capacity and technology for larger drone platforms. Short-term pain for long-term positioning. Defense acquisitions routinely take 12-18 months to fully integrate — AVAV is seven months in. Judging the deal on Q3 margins is like reviewing a construction project when the framing isn't finished.
Forward Outlook: Recovery Path to Profitability
Analyst consensus for FY2028 projects quarterly revenue of $595-$770 million, implying annual revenue around $2.64 billion. Expected EPS ranges from $1.11 to $2.01 per quarter ($5.73 annually), marking a decisive return to profitability.
The path from here to there requires gross margins recovering toward 30%+ as integration completes, SG&A leverage improving on a larger revenue base, and contract timing normalizing. Management's credibility took a hit with the guidance cut, but the underlying demand drivers — NATO drone procurement, US DoD modernization, counter-drone systems — are strengthening, not weakening.
Next earnings on June 23, 2026 will be critical. Any sign of margin recovery or order book strength could snap the stock back toward the $250 level. The 50-day average sits at $250, and the stock would need a 37% rally just to reach it — large, but not unusual for <a href="/posts/cyber-stocks-rally-as-geopolitical-risk-rewires-tech-spending">defense stocks</a> after sentiment troughs.
Debt-to-equity at 0.19 and a current ratio of 5.51 mean AVAV has the <a href="/posts/how-to-read-a-balance-sheet-step-by-step">balance sheet</a> to weather the integration period without issuing equity or taking on distressed financing.
Conclusion
Wall Street downgraded AeroVironment at the worst possible time — after a non-cash impairment charge, during acquisition integration, and right before the global drone market enters its steepest growth phase. The stock at $183 prices in permanent margin destruction that is almost certainly temporary.
The risks are real: SCAR contract competition, continued integration drag, and lumpy defense revenue that could disappoint in any given quarter. But at 2.1x book value with zero debt risk, investors are getting the leading tactical drone company at a price that assumes the drone revolution somehow passes it by. Buy the fear. The next two quarters will prove whether management can deliver the margin recovery — but at this price, you're being compensated for the uncertainty.
Frequently Asked Questions
Sources & References
www.trefis.com
primaryignition.com
www.tipranks.com
Disclaimer: This content is for informational purposes only and does not constitute financial advice. Consult qualified professionals before making investment decisions.